当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析 - 现金流量表

迈威生物-U

(688062)

  

流通市值:80.26亿  总市值:157.08亿
流通股本:2.04亿   总股本:4.00亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金784,231,938.25484,917,067.4355,090,410.77222,438,243.27
  收到的税费返还---1,001,103.89
  收到其他与经营活动有关的现金78,534,635.269,865,618.884,291,650.04141,624,254.02
  经营活动现金流入小计862,766,573.45554,782,686.3159,382,060.81365,063,601.18
  购买商品、接受劳务支付的现金8,395,722.256,782,481.151,576,538.6729,069,018.5
  支付给职工以及为职工支付的现金366,163,109.94259,378,037.61109,071,015.94468,090,653.05
  支付的各项税费38,664,708.1210,936,683.636,362,782.4421,977,121.19
  支付其他与经营活动有关的现金552,574,502.73311,609,944.55158,988,464.93802,370,438.62
  经营活动现金流出小计965,798,043.04588,707,146.94275,998,801.981,321,507,231.36
  经营活动产生的现金流量净额-103,031,469.59-33,924,460.63-216,616,741.17-956,443,630.18
二、投资活动产生的现金流量:
  收回投资收到的现金181,873,582.1841,873,582.1831,873,582.18382,459,886.99
  取得投资收益收到的现金531,987.94302,196.27282,196.272,987,529.87
  投资活动现金流入小计182,405,570.1242,175,778.4532,155,778.45385,447,416.86
  购建固定资产、无形资产和其他长期资产支付的现金131,275,194.687,210,321.3235,441,639.18330,068,047.25
  投资支付的现金225,635,960.2642,630,877.6642,387,334.98346,933,530.18
  取得子公司及其他营业单位支付的现金26,555,538.4812,560,621.089,304,163.76-
  投资活动现金流出小计383,466,693.34142,401,820.0687,133,137.92677,001,577.43
  投资活动产生的现金流量净额-201,061,123.22-100,226,041.61-54,977,359.47-291,554,160.57
三、筹资活动产生的现金流量:
  吸收投资收到的现金200,000,000200,000,000--
  其中:子公司吸收少数股东投资收到的现金200,000,000200,000,000--
  取得借款收到的现金1,285,840,000867,140,000651,840,0003,605,480,873.49
  收到其他与筹资活动有关的现金200,000,000100,000,000100,000,0002,892,417.2
  筹资活动现金流入小计1,685,840,0001,167,140,000751,840,0003,608,373,290.69
  偿还债务支付的现金1,023,767,117.94792,468,562.31533,172,555.632,669,130,225.01
  分配股利、利润或偿付利息支付的现金57,896,342.1241,051,813.423,155,253.166,111,902.52
  支付其他与筹资活动有关的现金86,929,089.5838,255,764.4414,379,662.2941,433,330.94
  筹资活动现金流出小计1,168,592,549.64871,776,140.15570,707,471.022,776,675,458.47
  筹资活动产生的现金流量净额517,247,450.36295,363,859.85181,132,528.98831,697,832.22
四、汇率变动对现金及现金等价物的影响-1,291,825.48-153,575.87-138,837.15232,889
五、现金及现金等价物净增加额211,863,032.07161,059,781.74-90,600,408.81-416,067,069.53
  加:期初现金及现金等价物余额1,227,566,165.231,227,566,165.231,227,566,165.231,643,633,234.76
  期末现金及现金等价物余额1,439,429,197.31,388,625,946.971,136,965,756.421,227,566,165.23
补充资料:
  净利润--552,229,971.82--1,046,564,705.48
  资产减值准备-7,689,770.12-5,526,750.78
  固定资产和投资性房地产折旧-88,831,754.32-93,556,473.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-88,831,754.32-93,556,473.38
  无形资产摊销-3,950,097.2-18,800,120.51
  长期待摊费用摊销-683,533.49-1,503,622.62
  递延收益摊销-307,233.33-16,481,698.53
  固定资产报废损失---113,812.15
  公允价值变动损失--18,138.89--493,457.59
  财务费用-39,669,599.2-58,526,661.97
  投资损失-2,865,785.93-4,218,903.47
  递延所得税-0-0
  其中:递延所得税资产减少-3,242,372.45-6,845,605.13
    递延所得税负债增加--3,242,372.45--6,845,605.13
  存货的减少--6,847,580.81--57,909,335.94
  经营性应收项目的减少--13,076,265.95--77,362,611.67
  经营性应付项目的增加-381,297,671.28--36,242,173.54
  现金的期末余额-1,388,625,946.97-1,191,693,931.96
  减:现金的期初余额-1,191,693,931.96-1,643,633,234.76
  加:现金等价物的期末余额---35,872,233.27
  减:现金等价物的期初余额-35,872,233.27--
  现金及现金等价物的净增加额-161,059,781.74--416,067,069.53
公告日期2025-10-312025-08-302025-04-292025-03-31
审计意见(境内)标准无保留意见
TOP↑